Special Interest Applications
- Administration of Agents to Dogs
- Administration of Agents to Neonatal Rats
- Administration of Agents to SCID Mice
- Administration of Agents to Livestock
- Administration of Agents to Primates
- Agent Stability
- Cancer Research Alert (April 2015)
- Measuring Cell Proliferation In Vivo (continuous BrdU or 3H-thymidine labeling)
- Chronic Delivery Research Alert (July 2013)
- Delayed CNS Infusion
- Extended Duration (studies where delivery duration was extended by serial pump implantation)
- Functionality (studies where in vivo pump performance was measured)
- Hormone Replacement (studies where exogenous hormone effects were determined in the absence of endogenous hormone production)
- Humanized Mose Models Research Alert (September 2014)
- Humanized mouse models references
- Injection-Infusion Comparisons (studies which compare the effects of drugs when given by injection and infusion)
- Intravenous Administration of Agents to Mice
- In Vitro Drug Delivery
- Long Term Infusion (delivery for six weeks or longer)
- Multiple Pumps Per Animal
- Neuroscience Research Alert (June 2014)
- Post Op Care (studies where the type of post operative care was mentioned)
- Pulsatile Administration (studies in which pumps were modified to deliver in a pulsatile manner)
- Translational Research Alert (April 2013)
- Use of ALZET Pumps in Space
If you are interested in a specific agent and did not find it listed above, check the index by Agent Administered.
Additional technical information is available on using ALZET pumps to deliver proteins and peptides.
*Some of these bibliographies may be large and take a short while to display. These bibliographies are updated frequently. As the references are listed most recent first, you may wish to truncate your printing to ten pages or less.
Since 1977, scientist around the world have used ALZET pumps to conduct their research, publishing their results in high-impact journals. The ALZET bibliography now contains over 16,000 publications! We can perform a custom search for references relevant to your research.
What researchers are saying...
“A continuous infusion paradigm was utilized in both experiments to minimize any potential hemodynamic side effects from bolus NTG administration... Cha et al., Pharm Bioch and Behav 2003;74:551-557.